InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Browse the detailed record of transactions filed by Solomons Neil, Directeur Médical. Insider active across 1 companies, notably Aurinia Pharmaceuticals Inc.. Aggregated, 11 filings have been published. Total volume traded: €4m. The latest transaction was disclosed on 2 March 2022 — Attribution. Regulator: SEC (Form 4). All data is openly available.
Declarations11 total
08,500 shares0
Common Stock
SEC:0001628280-22-005119:0·
€1m50,000 shares@ €26.027750.1% of flow
Common Shares
SEC:0001628280-21-023153·
€1m50,000 shares@ €26.02770.062% mcap25.1% of flow
Common Shares
SEC:0001628280-21-023153:0·
€206,37445,000 shares@ €4.58617.9% of flow
Common Stock
SEC:0001628280-21-021484·
€206,37445,000 shares@ €4.58610.0098% mcap4.0% of flow
Common Stock
SEC:0001628280-21-021484:0·
€406,368150,000 shares@ €2.709115.7% of flow
Common Shares
SEC:0001628280-21-018594·
€406,368150,000 shares@ €2.70910.019% mcap7.8% of flow
Common Shares
SEC:0001628280-21-018594:0·
€67,3075,000 shares@ €13.46142.6% of flow
Common Stock
SEC:0001628280-21-017662·
€67,3075,000 shares@ €13.46140.0032% mcap1.3% of flow
Common Stock
SEC:0001628280-21-017662:0·
€614,51845,000 shares@ €13.65623.7% of flow
Common Stock
SEC:0001628280-21-016407·
€614,51845,000 shares@ €13.6560.029% mcap11.8% of flow
Common Stock
SEC:0001628280-21-016407:0·
11 of 11 declarations
About Solomons Neil
Neil Solomons is the Chief Medical Officer at Aurinia Pharmaceuticals Inc. He oversees the company's clinical and research initiatives, ensuring innovation in the field of pharmaceuticals. His medical expertise is essential for the development of new therapies.
